Allegra Allergy

Allegra Allergy
SPL v19
SPL
SPL Set ID f061d6b1-89f7-4d5f-ac59-9c73408517c1
Route
ORAL
Published
Effective Date 2025-02-19
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Fexofenadine (180 mg)
Inactive Ingredients
Croscarmellose Sodium D&c Red No. 28 D&c Red No. 33 Fd&c Blue No. 1 Gelatin Hydroxypropyl Cellulose (1600000 Wamw) Hypromelloses Magnesium Stearate Cellulose, Microcrystalline Polyethylene Glycol 6000 Starch, Corn Titanium Dioxide

Identifiers & Packaging

Pill Appearance
Imprint: AG;AG Shape: oval Color: purple Size: 20 mm Score: 1
Marketing Status
NDA Active Since 2014-12-17 Until 2019-06-23

Description

Allegra Allergy® Gelcaps   –   24 HO UR Drug Facts

Purpose

Antihistamine


Medication Information

Purpose

Antihistamine

Description

Allegra Allergy® Gelcaps   –   24 HO UR Drug Facts

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose

  • sneezing

  • itchy, water eyes

  • itching of the nose or throat
Section 42229-5

Allegra Allergy® Gelcaps     24 HO UR

Drug Facts

Directions
adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours
children under 12 years of age do not use
adults 65 years of age and older ask a doctor
consumers with kidney disease ask a doctor
Do Not Use

if you have ever had an allergic reaction to this product or any of its ingredients.

Active Ingredient

(in each tablet)

Fexofenadine HCI 180 mg

Other Information
  • safety sealed: do not use if carton is opened or if individual blister units are torn or opened

  • store between 20º and 25ºC (68º and 77ºF) 

  • protect from excessive moisture
Inactive Ingredients

croscarmellose sodium, D&C red 28, D&C red 33, FD&C blue 1, gelatin, hydroxypropylcellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, PEG-135, pharmaceutical ink, pregelatinized starch, titanium dioxide

Questions Or Comments?

call toll-free 1-800-633-1610 or www.allegra.com 

The makers of Allegra® do not make store brand products. The trade dress of this Allegra® package is subject to trademark protection.

Dist. By: Chattem, Inc., a Sanofi Company, Chattanooga, TN 37409-0219 ©2014

Principal Display Panel

NDC 41167-4122-0

Allegra® 

ALLERGY

fexofenadine HCI tablet

180 mg/antihistamine

24 HR

8 GELCAPS 

Stop Use and Ask A Doctor If

an allergic reaction to this product occurs. Seek medical help right away.

If Pregnant Or Breast Feeding,

ask a health professional before use.

Keep Out of Reach of Children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Ask A Doctor Before Use If You Have

kidney disease. Your doctor should determine if you need a different dose.

When using this product

  • do not take more than directed

  • do not take at the same time as aluminum or magnesium antacids

  • do not take with fruit juices (see Directions)

Structured Label Content

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose

  • sneezing

  • itchy, water eyes

  • itching of the nose or throat
Section 42229-5 (42229-5)

Allegra Allergy® Gelcaps     24 HO UR

Drug Facts

Purpose

Antihistamine

Directions
adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours
children under 12 years of age do not use
adults 65 years of age and older ask a doctor
consumers with kidney disease ask a doctor
Do Not Use (Do not use)

if you have ever had an allergic reaction to this product or any of its ingredients.

Active Ingredient (Active ingredient)

(in each tablet)

Fexofenadine HCI 180 mg

Other Information (Other information)
  • safety sealed: do not use if carton is opened or if individual blister units are torn or opened

  • store between 20º and 25ºC (68º and 77ºF) 

  • protect from excessive moisture
Inactive Ingredients (Inactive ingredients)

croscarmellose sodium, D&C red 28, D&C red 33, FD&C blue 1, gelatin, hydroxypropylcellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, PEG-135, pharmaceutical ink, pregelatinized starch, titanium dioxide

Questions Or Comments? (Questions or comments?)

call toll-free 1-800-633-1610 or www.allegra.com 

The makers of Allegra® do not make store brand products. The trade dress of this Allegra® package is subject to trademark protection.

Dist. By: Chattem, Inc., a Sanofi Company, Chattanooga, TN 37409-0219 ©2014

Principal Display Panel (PRINCIPAL DISPLAY PANEL)

NDC 41167-4122-0

Allegra® 

ALLERGY

fexofenadine HCI tablet

180 mg/antihistamine

24 HR

8 GELCAPS 

Stop Use and Ask A Doctor If (Stop use and ask a doctor if)

an allergic reaction to this product occurs. Seek medical help right away.

If Pregnant Or Breast Feeding, (If pregnant or breast-feeding,)

ask a health professional before use.

Keep Out of Reach of Children. (Keep out of reach of children.)

In case of overdose, get medical help or contact a Poison Control Center right away.

Ask A Doctor Before Use If You Have (Ask a doctor before use if you have)

kidney disease. Your doctor should determine if you need a different dose.

When using this product

  • do not take more than directed

  • do not take at the same time as aluminum or magnesium antacids

  • do not take with fruit juices (see Directions)

Advanced Ingredient Data


Raw Label Data

All Sections (JSON)